Bain Capital Specialty Finance (BCSF) Cash & Equivalents (2021 - 2026)

Bain Capital Specialty Finance has reported Cash & Equivalents for 6 years, with the latest figure at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 33.66% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (up 33.66% YoY), and the FY2025 full-year result was $38.8 million, down 62.53% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $13.6 million, down from $38.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $128.6 million in Q2 2023, with the low at $10.2 million in Q1 2025.
• Average Cash & Equivalents over 5 years is $57.7 million, with a median of $40.9 million recorded in 2025.
• Year-over-year, Cash & Equivalents soared 305.89% in 2024 and slumped 89.14% in 2025.
• Tracing BCSF's Cash & Equivalents over 5 years: stood at $125.7 million in 2022, then tumbled by 65.8% to $43.0 million in 2023, then surged by 140.92% to $103.6 million in 2024, then sank by 62.53% to $38.8 million in 2025, then tumbled by 64.98% to $13.6 million in 2026.
• The last three Cash & Equivalents figures came in at $13.6 million (Q1 2026), $38.8 million (Q4 2025), and $40.9 million (Q3 2025), per Business Quant data.

Peer Comparison